FDA product code NGB: Test, Glycosylated Hemoglobin, Over The Counter
NGB is the FDA product code for test, glycosylated hemoglobin, over the counter. It is a Class II device, regulated under 21 CFR 864.7470 and reviewed by the Clinical Toxicology panel. Devices under NGB reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Test, Glycosylated Hemoglobin, Over The Counter |
| Device class | Class II |
| Regulation | 21 CFR 864.7470 |
| Review panel | TX — Clinical Toxicology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
Recalls for NGB devices
FDA recall records list no recalls for product code NGB.
Frequently asked questions
What is FDA product code NGB?
NGB is the FDA product code for test, glycosylated hemoglobin, over the counter. It is a Class II device, regulated under 21 CFR 864.7470 and reviewed by the Clinical Toxicology panel.
What device class is NGB?
Class II, regulation 21 CFR 864.7470. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code NGB
- Run a recall and safety report across every NGB manufacturer
- Watch product code NGB for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times